PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. Show more
150 Baytech Drive, San Jose, CA, 95134, United States
Market Cap
1.53B
52 Wk Range
$19.35 - $66.85
Previous Close
$27.13
Open
$27.13
Volume
1,524,935
Day Range
$26.97 - $28.19
Enterprise Value
1.322B
Cash
286.5M
Avg Qtr Burn
-10.33M
Insider Ownership
4.76%
Institutional Own.
-
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
